§105. Reportable Diseases and Conditions
A. - C. ...
D. The following diseases or conditions are hereby declared reportable with reporting requirements by class.
1. Class A Diseases or Conditions which Shall Require Reporting within 24 Hours
a. Class A diseases or conditions include diseases or conditions of major public health concern because of the severity of the disease or condition and the potential for epidemic spread. Class A diseases or conditions shall be reported to the Office of Public Health by telephone (or in another electronic format acceptable to the Office of Public Health) immediately upon recognition that a case, a suspected case, or a positive laboratory result is known. In addition, all cases of rare or exotic communicable diseases, unexplained death, unusual clusters of disease and all outbreaks shall be reported. Any class A disease or condition, rare or exotic communicable disease, unexplained death, or unusual cluster of disease and any disease outbreak, shall be reported to the Office of Public Health as soon as possible but no later than 24 hours from recognition that a case, a suspected case, a positive laboratory result, an unexplained death, an unusual cluster of disease, or a disease outbreak is known. The following diseases or conditions shall be classified as class A for reporting requirements:
a.i. - x. â¦
xi. coronavirus disease 2019 (COVID19)/infections with SARS-CoV-2;
xii. diphtheria;
xiii. Enterobacteriacea, carbenum-resistant;
xiv. fish or shellfish poisoning (domoic acid poisoning, neurotoxic shellfish poisoning, ciguatera, paralytic shellfish poisoning, scombroid);
xv. food-borne illness;
xvi. glanders (Burkholderia mallei);
xvii. Haemophilus influenzae (invasive infection);
xviii. influenza-associated mortality;
xix. measles (rubeola, imported or indigenous);
xx. melioidosis (Burkholderia pseudomallei);
xxi. Neisseria meningitidis (invasive infection);
xxii. outbreaks of any infectious diseases;
xxiii. pertussis;
xxiv. plague (Yersinia pestis);
xxv. poliomyelitis (paralytic and non-paralytic);
xxvi. Pseudomonas aeruginosa, carbapenemresistant;
xxvii. Q fever (Coxiella burnettii);
xxviii. rabies (animal and human);
xxiv. ricin poisoning;
xxx. rubella (congenital syndrome);
xxxi. rubella (German measles);
xxxii. severe acute respiratory syndrome-associated coronavirus (SARS-CoV);
xxxiii. Staphylococcus aureus, vancomycin intermediate or resistant (VISA.VRSA);
xxxiv. staphylococcal enterotoxin B (SEB) pulmonary poisoning;
xxxv. smallpox;
xxxvi. tularemia (Francisella tularensis);
xxxvii. viral hemorrhagic fever (Ebola, Lassa, Marburg, Crimean Congo, etc.); and
xxxviii. yellow fever.
D.2. - E.6. â¦
AUTHORITY NOTE: Promulgated in accordance with the provisions of R.S. 40:4(A)(2) and R.S. 40:5(2)(10)(11).
HISTORICAL NOTE: Promulgated by the Department of Health and Hospitals, Office of Public Health, LR 28:1212 (June 2002), amended LR 32:1050 (June 2006), LR 34:2173 (October 2008), repromulgated LR 34:2582 (December 2008), LR 36:1014 (May 2010), repromulgated LR 36:1253 (June 2010), amended LR 39:1053 (April 2013), LR 41:2653 (December 2015), amended by the Department of Health, Office of Public Health, amended LR 45:667 (May 2019), LR 46:
§107. Laboratory and Healthcare Facility Reporting Requirements
A - E. â¦
F. Electronic reporting by a laboratory/facility shall include any results, negative or positive, for all components of testing indicative of the following conditions:
1. coronavirus disease 2019 (COVID-19)/infections with SARS-CoV-2;
2. hepatitis C virus;
3. human immunodeficiency virus (HIV), including nucleotide sequences; and
4. syphilis.
G. â¦
AUTHORITY NOTE: Promulgated in accordance with the provisions of R.S. 40:4(A)(2) and R.S. 40:5(2)(10)(11).
HISTORICAL NOTE: Promulgated by the Department of Health and Hospitals, Office of Public Health, LR 28:1214 (June 2002), amended LR 32:1052 (June 2006), LR 39:1054 (April
2013), LR 41:2655 (December 2015), amended by Department of Health, Office of Public Health, LR 45:669 (May 2019), LR 46: